VR Logo

Sonoma Pharmaceuticals Inc. (SNOA) download report


Healthcare | Drugs & Pharma

Sonoma Pharmaceuticals Inc. (SNOA) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally.

IPO Date: 25-Jan-2007

CEO & Pres: Ms. Amy M. Trombly

Chief Financial Officer: Mr. Jerome Dvonch

Listing: NASDAQ: SNOA

Country: United States

Headquarters: Woodstock, GA

Website: https://www.sonomapharma.com

Key Facts

Market cap: $9.28 Mln

Revenue (TTM): $10.96 Mln

Earnings (TTM): $-5.80 Mln

Cash: $8.53 Mln

Total Debt: $1.21 Mln

Insider's Holding: 0.54%

Liquidity: Low

52 Week range: $2.55 - 13.36

Shares outstanding: 3,097,670

10 Years Aggregate:

  • CFO: $-63.50 Mln
  • EBITDA: $-56.22 Mln
  • Net Profit: $-51.14 Mln

Stock Performance

Time Period Sonoma Pharmaceuticals (SNOA) S&P BSE Healthcare S&P Small-Cap 600
YTD-34.87-17.55-19.23
1 month-11.87-3.85-9.35
3 months-11.61-11.97-16.59
1 Year-60.92-15.43-17.36
3 Years-27.8918.795.90
5 Years-45.629.095.77
10 Years-35.3612.129.78
As on 30-Jun-2022
Year Sonoma Pharmaceuticals (SNOA) S&P Small-Cap 600 S&P BSE Healthcare
2021-37.1925.2720.87
202066.519.5761.45
2019-32.0120.86-3.55
2018-86.78-9.70-5.89
20178.1311.730.49
2016-12.3524.74-12.88
2015-19.58-3.3615.06